Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,099 public trials 2,041 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Trial of Ibrutinib Plus Venetoclax Plus Obinutuzumab in Patients With CLL

NCT02758665

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +14 more
Locations
  • Universitätsklinikum Köln Cologne, Germany
  • BAG Onkologische Gemeinschaftspraxis Dresden, Germany
  • Universitätsklinikum Essen Essen, Germany
  • Universitätsklinikum Freiburg Freiburg im Breisgau, Germany
View Trial Details
Completed

Observational Study to Monitor Safety and Effectiveness of Obinutuzumab in Follicular Lymphoma or Previously Untreated Chronic Lymphocytic Leukemia

NCT03374137

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +18 more
Locations
  • Inje University Busan Paik Hospital; Hematology-oncology Busan, South Korea
  • Pusan National University Hospital Busan, South Korea
  • St. Vincent's Hospital Gyeonggi-do, South Korea
  • Hallym University Sacred Heart Hospital; Department of Hematology Gyeonggi-do, South Korea
View all 17 locations
View Trial Details
Completed

Efficacy and Safety of Romidepsin CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma

NCT01796002

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • ZNA Stuivenberg Antwerp, Belgium
  • A.Z. Sint Jan AV Bruges, Belgium
  • Institut Jules Bordet Brussels, Belgium
  • UCL Louvain Saint Luc Brussels, Belgium
View all 131 locations
View Trial Details
Completed

High-definition Videobronchoscopy in Sarcoidosis

NCT04743596

Conditions
Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +4 more
Locations
  • Azienda Ospedaliero Universitaria di Bologna Bologna, Italy
  • Fondazione Policlinico Univeristario A. Gemelli IRCCS Roma, Italy
  • Academic Medical Centre Amsterdam, Netherlands
  • Central TB Research Institute Moscow, Russia
View Trial Details

Related conditions